17, 2024 — Axi-cel CAR T targets the CD19 molecule on large B-cell lymphoma cells. The ZUMA-7 trial demonstrated that axi-cel reduced the risk of disease progression, the need for new therapy ...

Calquence is under clinical development by AstraZeneca and currently in Phase II for Graft Versus Host Disease (GVHD).

Calquence is under clinical development by AstraZeneca and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable. There have been a number of advancements in the treatment of follicular lymphoma in 2024.

Certain symptoms and physical findings may be detected, and a variety of specialized tests are used to confirm the specific type and subtype of non-Hodgkin's lymphoma (NHL), to determine the extent of ...

The main types of B-cell non-Hodgkin lymphoma (NHL) are listed here, along with estimates for the number of new cases annually expected in the United States: Today, SLL and CLL are often considered ...

More than 400 people have been affected by an undiagnosed illness that some are calling "Disease X," in the Democratic Republic of the Congo (DRC)—specifically, Panzi health zone, Kwango ...

A mysterious illness, which the Africa Centers for Disease Control and Prevention is calling "disease X," has killed at least 31 people — mostly children — in the remote Panzi region of the ...

‘Disease X’ Outbreak Widens as UN Sends Health Team to Congo The number of reported cases of flu-like illness rises to 416 Headache, cough, runny nose and body aches are among symptoms ...

Department of Hepatobiliary Surgery of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Preface and importance: Burkitt’s lymphoma ...